CBD Nutraceuticals Market is estimated to Reach USD 17.9

Covina, Feb. 27, 2024 (GLOBE NEWSWIRE) — “According to the recent research study, the CBD Nutraceuticals Market size was valued at about USD 4.5 Billion in 2024 and expected to grow at CAGR of 16.40% to extend a value of USD 17.9 Billion by 2034.”

What is CBD Nutraceuticals?

Market Overview:

CBD nutraceuticals refer to products that combine cannabidiol (CBD), a compound derived from the cannabis plant, with nutraceutical ingredients to create health and wellness products. Nutraceuticals are products that provide health benefits beyond basic nutritional value and are often associated with the prevention and treatment of various medical conditions.

In the context of CBD nutraceuticals, CBD is the primary active ingredient, and it is often sourced from hemp plants, which contain low levels of THC (tetrahydrocannabinol), the psychoactive compound found in marijuana. CBD is believed to interact with the endocannabinoid system in the body, which plays a role in regulating various physiological processes.

Get Access to Free Sample Research Report with Latest Industry Insights:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4230

*Note: PMI Sample Report includes,

• Overview & introduction of market study
• Revenue and CAGR of market 
• Drivers & Restrains factors of market 
• Major key players in market 
• Regional analysis of the market with a detailed graph
• Detailed segmentation in tabular form of market 
• Recent development/news of market 
• Opportunities & Challenges of Market 

Top Leading Players in CBD Nutraceuticals Market:

• Bluebird Botanicals
• CV Sciences, Inc.
• Elixinol LLC
• Endoca BV
• Foria Wellness
• Irwin Naturals
• Diamond CBD
• Isodiol
• Medical Marijuana
• Medterra

Market Dynamics:

Driving Factors:

• There is a rising trend towards natural health and wellness solutions, driven by increasing consumer awareness of the potential benefits of CBD and other botanical compounds. Consumers seek alternatives to conventional pharmaceuticals and are attracted to the perceived natural and holistic properties of CBD nutraceuticals.
• The legalization of hemp-derived CBD products in many regions, along with clearer regulations governing their production, distribution, and sale, has created opportunities for market expansion. Regulatory clarity provides a more stable operating environment for CBD nutraceutical manufacturers and retailers, leading to increased consumer confidence and market growth.
• The CBD nutraceuticals market is characterized by a wide range of product offerings, including oils, capsules, edibles, topicals, and beverages. Manufacturers continue to innovate by introducing new formulations, flavors, and delivery methods to cater to consumer preferences and expand market reach.
• CBD nutraceuticals are increasingly accepted and integrated into mainstream healthcare and wellness practices. Healthcare professionals, wellness experts, and celebrities endorse CBD products, contributing to greater consumer acceptance and adoption of CBD as part of a healthy lifestyle.

Restrain Factors:

• Lack of standardization
• Concerns about product safety
• Limited clinical evidence

Emerging Trends and Opportunities in CBD Nutraceuticals Market:

• Manufacturers are exploring innovative formulations, delivery methods, and product formats to differentiate their CBD nutraceutical offerings and cater to diverse consumer needs and preferences. Novel formulations such as nano-emulsions, liposomal delivery systems, and water-soluble CBD enhance bioavailability and improve product efficacy.
• There is growing demand for CBD nutraceuticals formulated with targeted ingredients and functional additives to address specific health concerns and wellness goals. Formulations combining CBD with adaptogens, botanical extracts, vitamins, and minerals offer synergistic benefits and appeal to consumers seeking holistic wellness solutions.
• The integration of CBD into beauty and personal care products, including skincare, haircare, and cosmetics, is a burgeoning trend in the CBD nutraceuticals market. CBD-infused beauty products are valued for their potential anti-inflammatory, antioxidant, and soothing properties, appealing to consumers interested in natural and sustainable skincare solutions.
• The pet CBD segment is experiencing rapid growth, driven by increasing consumer awareness of the potential health benefits of CBD for pets and rising demand for natural and alternative pet care products. CBD-infused pet supplements, treats, and grooming products target various pet health concerns, including anxiety, pain management, inflammation, and age-related issues.
• The expansion of retail channels and distribution networks broadens market access and enhances consumer convenience and accessibility to CBD nutraceuticals. Brick-and-mortar retailers, online platforms, specialty stores, pharmacies, and wellness dispensaries serve as key distribution channels for CBD products, reaching diverse consumer demographics and geographic regions.

Download PDF Brochure:

https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/4230

Challenges of CBD Nutraceuticals Market:

• Regulatory frameworks governing the production, distribution, and sale of CBD nutraceuticals vary widely across jurisdictions, creating uncertainty for manufacturers, retailers, and consumers. Inconsistent regulations, evolving guidelines, and ambiguous legal status of CBD complicate compliance efforts and market entry strategies.
• Ensuring product quality, purity, and safety is a significant challenge in the CBD nutraceuticals market. Quality control issues, including inconsistent CBD potency, mislabeling, and contamination with pesticides, heavy metals, or residual solvents, pose risks to consumer health and erode trust in CBD products.

Detailed Segmentation:

CBD Nutraceuticals Market, By Product type:

• • • CBD Tinctures
    • Capsules & Softgels
    • CBD Gummies
    • Others

CBD Nutraceuticals Market, By Sales Channel:

• • • Retail Stores
    • Online
    • Pharmacies

CBD Nutraceuticals Market, By Region:

• • • North America
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

Regional Analysis:

Regional insights highlight the diverse market dynamics, regulatory landscapes, and growth drivers shaping the CBD Nutraceuticals Market across different geographic areas. Understanding regional nuances and market trends is essential for stakeholders to capitalize on emerging opportunities and drive market expansion in the CBD Nutraceuticals sector.

North America market is estimated to witness the fastest share over the forecast period as the legal status of CBD in North America varies by jurisdiction. In the United States, the Agriculture Improvement Act of 2018, also known as the Farm Bill, legalized the cultivation and commercial production of hemp-derived CBD products containing less than 0.3% THC (tetrahydrocannabinol). Similarly, in Canada, the Cannabis Act legalized the production, distribution, and sale of cannabis-derived products, including CBD, for medical and recreational use.

Report scope:

Attribute	Details
Market Size 2024	US$ 4.5 Billion
Projected Market Size 2034	US$ 17.9 Billion
CAGR Growth Rate	16.40%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product type- CBD Tinctures, Capsules & Softgels, CBD Gummies, and Others By Sales channel – Retail Stores, Online, and Pharmacies
Regional scope	North America – U.S., Canada Europe – UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific – Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America – Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Key highlights of the CBD Nutraceuticals Market:

• The CBD Nutraceuticals market is heavily influenced by regulatory requirements and oversight from health authorities worldwide. Pharmaceutical companies are mandated to establish CBD Nutraceuticals systems, adhere to reporting obligations, and comply with regulatory standards to ensure the safety of pharmaceutical products.
• The globalization of pharmaceutical markets and the harmonization of CBD Nutraceuticals standards facilitate international collaboration, information-sharing, and alignment of regulatory practices. Harmonization initiatives promote consistency in CBD Nutraceuticals regulations, guidelines, and reporting requirements across regions and countries.
• Technological advancements, including artificial intelligence (AI), machine learning, big data analytics, and digital health solutions, are transforming CBD Nutraceuticals practices. Advanced technologies enable the efficient analysis of large volumes of safety data, early detection of safety signals, and proactive risk management strategies.
• The growing complexity of drug development, expanding therapeutic landscapes, and rising concerns about medication safety drive the demand for CBD Nutraceuticals services. Pharmaceutical companies, contract research organizations (CROs), and CBD Nutraceuticals service providers seek expertise in safety monitoring, risk assessment, and regulatory compliance.
• Pharmaceutical companies increasingly outsource CBD Nutraceuticals activities to specialized service providers and CROs to optimize resource allocation, reduce operational costs, and ensure compliance with regulatory requirements. Collaboration among stakeholders, including regulatory agencies, healthcare professionals, and industry partners, fosters knowledge sharing, best practices, and innovation in CBD Nutraceuticals.
• Real-world evidence (RWE) generated from electronic health records, claims databases, patient registries, and other sources complements traditional clinical trial data in CBD Nutraceuticals. RWE enhances safety monitoring, post-market surveillance, and risk assessment by providing insights into drug effectiveness, safety outcomes, and treatment patterns in real-world clinical practice.

Any query or customization before buying:

https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/4230

Explore More Insights:

Blog: www.prophecyjournals.com

Follow us on:

LinkedIn | Twitter | Facebook |YouTube